[Congressional Record Volume 144, Number 106 (Friday, July 31, 1998)]
[Senate]
[Page S9620]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                      TRIBUTE TO CHRISTINE JACOBS

 Mr. CLELAND. Mr. President, I rise today to honor the many 
accomplishments of Christine Jacobs of Norcross, Georgia. Chris is the 
President, CEO and Chairman of the Board of Theragenics Corporation 
which markets, sells and distributes the FDA-licensed medical device 
TheraSeed for treating cancer.
  She has had many remarkable accomplishments during her career, but 
today I would like to call attention to yet another important 
milestone. On August 6, 1998 Chris will switch Theragenics from the 
NASDAQ exchange, which the company has been trading on publicly since 
1986, to the New York Stock Exchange. Chris will become the first 
female CEO to enroll a company on the New York Stock Exchange. She will 
also be ringing the bell to open the exchange that morning.
  Chris Jacobs is truly a remarkable and successful business-savy 
member of the Georgia business community. She also dedicates time to 
civic and medical organizations in Georgia including the Georgia Bio-
Medical Partnership, the Board of Councilors of the Carter Center, the 
State's Small Business Taskforce and the Georgia Chamber of Commerce.
  Chris Jacobs possesses the tenacity and vision that has changed the 
world as we have known it and paved the road to the next millennium in 
regard to medical treatment. I ask my colleagues in the Senate to join 
me in honoring the innumerable achievements of Chris Jacobs and her 
work at Theragenics, and wish her luck and much success on the New York 
Stock Exchange. She proves that if we can perceive it we can achieve 
it--Chris will continue to rewrite history and achieve unending 
successes.




                          ____________________